SOPHiA GENETICS (SOPH) Operating Expenses (2020 - 2026)

SOPHiA GENETICS has disclosed Operating Expenses across 7 years of filings, most recently posting -$23.9 million for Q2 2026.

• In Q2 2026, Operating Expenses fell 15.1% year-over-year to -$23.9 million; the TTM figure through Jun 2026 stood at -$92.4 million (down 14.18% YoY), while the FY2025 annual figure was -$86.8 million, down 13.08% from the prior year.
• Operating Expenses came in at -$23.9 million for Q2 2026 at SOPHiA GENETICS, down from -$23.2 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of -$18.5 million in Q2 2024 to a low of -$23.9 million in Q2 2026.
• Average Operating Expenses over 5 years is -$21.9 million, with a median of -$22.1 million recorded in 2024.
• Year-over-year, Operating Expenses sank 62.14% in 2022 and increased 19.15% in 2024.
• Over 5 years, Operating Expenses stood at -$20.7 million in 2022, then fell by 5.5% to -$21.9 million in 2023, then grew by 5.43% to -$20.7 million in 2024, then slipped by 12.77% to -$23.3 million in 2025, then retreated by 2.67% to -$23.9 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were -$23.9 million in Q2 2026, -$23.2 million in Q1 2026, and -$23.3 million in Q4 2025.